Retour
28
50
Fourchette du Jour
188,42 €
196,12 €
Fourchette 52 Semaines
178,26 €
274,93 €
Volume
200 840
Moyenne 50J / 200J
236,81 €
/
224,47 €
Clôture Précédente
189,57 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 21,5 | 0,2 |
| P/B | 3,5 | 3,0 |
| ROE % | 17,8 | 3,6 |
| Net Margin % | 11,3 | 3,8 |
| Rev Growth 5Y % | 30,7 | 9,9 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
298,00 €
+56.8%
Low: 252,00 €
High: 344,00 €
P/E Prévisionnel
20,01
BPA Prévisionnel
9,50 €
Croissance BPA (est.)
+0,0%
CA Est.
638,97M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
10,67 €
10,32 € – 11,30 €
|
675,53M | 3 |
| FY2026 |
9,50 €
8,94 € – 9,92 €
|
638,97M | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | 2,07 € | 2,44 € | +17,9% |
| 2025-11-03 | 2,22 € | 2,39 € | +7,7% |
| 2025-08-04 | 2,29 € | 2,50 € | +9,2% |
| 2025-05-06 | 2,05 € | 2,47 € | +20,5% |
| 2025-02-25 | 1,98 € | 2,46 € | +24,2% |
| 2024-11-05 | 1,81 € | 2,11 € | +16,6% |
| 2024-07-31 | 1,53 € | 1,75 € | +14,4% |
| 2024-05-01 | 1,10 € | 1,64 € | +49,1% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 30,74% annually over 5 years — strong growth
Earnings grew 15,82% over the past year
ROE of 17,82% — decent returns on equity
Debt/Equity of 0,36 — conservative balance sheet
Generating 78,98M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 11,24%
Croissance
Revenue Growth (5Y)
30,74%
Revenue (1Y)19,50%
Earnings (1Y)15,82%
FCF Growth (3Y)60,02%
Qualité
Return on Equity
17,82%
ROIC11,97%
Net Margin11,33%
Op. Margin15,32%
Sécurité
Debt / Equity
0,36
Current Ratio2,68
Interest Coverage9,42
Valorisation
P/E Ratio
21,46
Forward P/E20,01
P/B Ratio3,46
EV/EBITDA17,33
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,50% | Revenue Growth (3Y) | 22,75% |
| Earnings Growth (1Y) | 15,82% | Earnings Growth (3Y) | 23,31% |
| Revenue Growth (5Y) | 30,74% | Earnings Growth (5Y) | 44,00% |
| Profitability | |||
| Revenue (TTM) | 602,80M | Net Income (TTM) | 68,31M |
| ROE | 17,82% | ROA | 10,26% |
| Gross Margin | 28,27% | Operating Margin | 15,32% |
| Net Margin | 11,33% | Free Cash Flow (TTM) | 78,98M |
| ROIC | 11,97% | FCF Growth (3Y) | 60,02% |
| Safety | |||
| Debt / Equity | 0,36 | Current Ratio | 2,68 |
| Interest Coverage | 9,42 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 21,46 | Forward P/E | 20,01 |
| P/B Ratio | 3,46 | P/S Ratio | 2,43 |
| PEG Ratio | 1,63 | Forward PEG | N/A |
| EV/EBITDA | 17,33 | Fwd EV/EBITDA | 14,09 |
| Forward P/S | 2,29 | Fwd Earnings Yield | 5,00% |
| FCF Yield | 5,39% | ||
| Market Cap | 1,47B | Enterprise Value | 1,60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 602,80M | 504,42M | 400,07M | 353,79M | 206,32M |
| Net Income | 68,31M | 58,98M | 44,92M | 41,79M | 15,89M |
| EPS (Diluted) | 8,77 | 7,58 | 5,83 | 5,45 | 2,09 |
| Gross Profit | 170,41M | 146,69M | 112,23M | 90,26M | 51,11M |
| Operating Income | 92,34M | 80,90M | 57,66M | 55,40M | 21,22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 665,74M | 629,00M | 404,14M | 378,19M | 334,13M |
| Total Liabilities | 241,86M | 286,24M | 118,05M | 140,65M | 139,69M |
| Shareholders' Equity | 423,88M | 342,76M | 286,09M | 237,55M | 194,45M |
| Total Debt | 154,48M | 206,03M | 46,04M | 68,37M | 84,36M |
| Cash & Equivalents | 20,30M | 13,45M | 5,26M | 4,45M | 11,12M |
| Current Assets | 201,00M | 194,95M | 144,63M | 116,35M | 87,32M |
| Current Liabilities | 74,86M | 76,30M | 58,21M | 55,96M | 38,78M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#877 of 1049
Custom
Balanced Risk
#59 of 153
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026